The IPA software was used to analyze the complex data set obtained from the gene array study. The genomic data was integrated from a variety of experimental platforms and the bar graph provides insight into the 6 main areas (of a multitude of molecular and chemical interactions, cellular phenotypes, and disease processes examined by the IPA software) that were identified to be highly affected in the cohort of individuals studied. IPA provides insight into the causes of observed gene expression changes and into the predicted downstream biological effects of those changes. The top 6 signaling pathways mapped by transcripts identified in microarray analysis are shown and the data is displayed as a bar chart. The bar chart represents a ratio of numbers of genes in the current study that directly overlaps with the ingenuity database for the respective canonical pathway. Within each of the 6 areas there are both upregulated and down-regulated genes. The percentage of up-regulated (red) and down-regulated (green) molecules are showed by the bars, while -log p value is displayed in the line graph.
The Ang-(1-7)-fusion transgene construct used in our study was described by Santos et al (Physiol Genomics. 2004; 17:292-299) . Briefly, the human prorenin signal peptide and the immunoglobulin fragment from mouse IgG2b were linked to a portion of the human prorenin prosegment, and the BglII site after the prorenin segment was used to insert a furin cleavage site and the coding sequence for Ang-(1-7). This construct was cloned into the PCR-Blunt TOPO vector (Invitrogen, Carlsbad, CA) and then subcloned from this vector into pTY-EF1α to set it under the control of human elongation factor1α. The control gene construct has a similar sequence except the coding sequence for Ang-(1-7). Vesicular stomatitis virus G protein (VSV-G) pseudotyped lentiviral particles were prepared, as previously described (Coleman et al. Physiol Genomics 2003; 12:221-228) . CD34 + cells were transduced at a concentration of 100 MOI, as described by Sengupta et al (Mol Ther .2009; 17:1594 -1604 . 
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